Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients
Karl Stattin, Miklós Lipcsey, Hanna Andersson, Emma Pontén, Sara Bülow Anderberg, Anna Gradin, Anders Larsson, Norbert Lübenow, Magnus von Seth, Sten Rubertsson, Michael Hultström, Robert Frithiof
Topics & Concepts
MedicineThromboelastographyCoagulopathyLow molecular weight heparinIntensive care unitCoagulationCritically illHeparinCoronavirus disease 2019 (COVID-19)AnesthesiaIntensive careInternal medicineIntensive care medicineDiseaseInfectious disease (medical specialty)Heparin-Induced Thrombocytopenia and ThrombosisCOVID-19 Clinical Research StudiesTrauma, Hemostasis, Coagulopathy, Resuscitation